Skip to Main Content

Paper Details

Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer.
Radiother Oncol
12
2014
Author NameAffiliation
Andre KonskiWayne State University, Barbara Ann Karmanos Cancer Center
  • 1 - 1

Datasets

Release 1.2